These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2481431)

  • 21. Adenoviral-expressed recombinant granulocyte monocyte colony-stimulating factor (GM-CSF) enhances protective immunity induced by inactivated Newcastle Disease Virus (NDV) vaccine.
    Wang X; Wang X; Jia Y; Wang C; Han Q; Lu ZH; Yang Z
    Antiviral Res; 2017 Aug; 144():322-329. PubMed ID: 28698014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge.
    Zhao R; Sun J; Qi T; Zhao W; Han Z; Yang X; Liu S
    Vaccine; 2017 Apr; 35(18):2435-2442. PubMed ID: 28342665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of fusion protein cleavage site in the virulence of Newcastle disease virus.
    Panda A; Huang Z; Elankumaran S; Rockemann DD; Samal SK
    Microb Pathog; 2004 Jan; 36(1):1-10. PubMed ID: 14643634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Saume E
    Avian Dis; 2008 Jun; 52(2):253-9. PubMed ID: 18646454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of interferon in interference and auto-interference elicited by Newcastle disease virus.
    Lomniczi
    Acta Microbiol Acad Sci Hung; 1975; 22(2):137-44. PubMed ID: 1168397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses of mature chicken bone-marrow-derived dendritic cells infected with Newcastle disease virus strains with differing pathogenicity.
    Xiang B; Zhu W; Li Y; Gao P; Liang J; Liu D; Ding C; Liao M; Kang Y; Ren T
    Arch Virol; 2018 Jun; 163(6):1407-1417. PubMed ID: 29397456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating viral interference between infectious bronchitis virus and Newcastle disease virus vaccine strains using quantitative reverse transcription-polymerase chain reaction.
    Gelb J; Ladman BS; Licata MJ; Shapiro MH; Campion LR
    Avian Dis; 2007 Dec; 51(4):924-34. PubMed ID: 18251404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
    Wajid A; Basharat A; Bibi T; Rehmani SF
    Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant-attenuated
    Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
    J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and protection efficacy evaluation of avian paramyxovirus serotype-1 (APMV-1) isolates in experimentally infected chickens.
    Omony JB; Wanyana A; Kirunda H; Mugimba KK; Nakavuma JL; Otim-Onapa M; Byarugaba DK
    Avian Pathol; 2017 Aug; 46(4):386-395. PubMed ID: 28277776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study on the pathogenesis of the generated 9a5b Newcastle disease virus mutant isolate between chickens and waterfowl.
    Anis Z; Morita T; Azuma K; Ito H; Ito T; Shimada A
    Vet Pathol; 2013 Jul; 50(4):638-47. PubMed ID: 23223199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
    Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
    J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated Challenge with Virulent Newcastle Disease Virus Does Not Decrease the Efficacy of Vaccines.
    Taylor TL; Miller PJ; Olivier TL; Montiel E; Cardenas Garcia S; Dimitrov KM; Williams-Coplin D; Afonso CL
    Avian Dis; 2017 Jun; 61(2):245-249. PubMed ID: 28665733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chicken ISG12(2) attenuates Newcastle disease virus and enhances the efficiency of Newcastle disease vaccine via activating immune pathways.
    Liu H; Tian J; Lu K; Li Y; Guan Z; Cao X; Li X; Chang Z; Wang X; Sa X; Yang Z
    Transbound Emerg Dis; 2022 Sep; 69(5):2634-2648. PubMed ID: 34904395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of host selective pressure on Newcastle disease virus virulence.
    Zanetti F; Berinstein A; Carrillo E
    Microb Pathog; 2008 Feb; 44(2):135-40. PubMed ID: 17900851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.
    Liu J; Zhu J; Xu H; Li J; Hu Z; Hu S; And XW; Liu X
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28809802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.